
Jan P. Nicolay
Mannheim, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 83 publications
Cellular and molecular aberrations generating new immunotherapeutic approaches in mycosis fungoides and Sézary syndrome: a comprehensive review of literature.
Journal: Frontiers in immunology
Published: June 03, 2026
Fungal Skin Infections in Cutaneous T-cell Lymphoma Patients under Mogamulizumab Treatment.
Journal: Acta dermato-venereologica
Published: May 13, 2026
Primary cutaneous acral CD8-positive lymphoproliferative disorder of the auricles: An unusual long-term course.
Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: April 17, 2026
Dupilumab therapy in atopic dermatitis when cutaneous lymphoma is suspected: Consensus recommendations from the EORTC Cutaneous Lymphoma Tumour Group.
Journal: The Journal of allergy and clinical immunology
Published: February 03, 2026
Brentuximab Vedotin in Advanced-Stage Mycosis Fungoides/Sézary Syndrome with Low CD30 Expression: Real-World Data from the German Cutaneous Lymphoma Network.
Journal: Cancers
Published: November 27, 2025
Prognostic factors in Sézary syndrome - a retrospective propensity score-matched study on 1277 patients.
Journal: Frontiers in immunology
Published: November 16, 2025
Extracorporeal photopheresis therapy rapidly changes the cytokine profile and tumor microenvironment in cutaneous T cell lymphoma.
Journal: Frontiers in immunology
Published: July 18, 2025
Brentuximab vedotin and radiotherapy for CD30-positive cutaneous T-cell lymphoma - a retrospective multicenter analysis.
Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: February 28, 2025
Exploring the integration of patient-reported outcome measures in clinical practice: A cross-sectional survey of EORTC healthcare professionals.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 16, 2025
CRISPR-Cas9 screen reveals that inhibition of enhancer of zeste homolog 2 sensitizes malignant T cells to dimethyl-fumarate-induced cell death.
Journal: The FEBS journal
Published: November 15, 2024
Low-dose total skin electron beam therapy in erythrodermic mycosis fungoides and Sézary syndrome: Results From the Prospective S-MISR Study.
Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: October 30, 2024
Last Updated: 09/26/2026